Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Acceleron Pharma Inc.

    NASDAQ: XLRN · Real-Time Price · USD
    178.75
    0.00 (0.00%)
    At close: Apr 24, 2025, 3:47 PM

    Acceleron Pharma Income Statement

    Financials in USD. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q3 2021 Q2 2021 Q1 2021
    Period Ending Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
    Revenue
    		 34.2M 27.94M 24.76M
    Cost of Revenue
    		 n/a n/a n/a
    Gross Profit
    		 34.2M 27.94M 24.76M
    Operating Income
    		 -70.63M -63.66M -63.6M
    Interest Income
    		 n/a n/a n/a
    Pretax Income
    		 -70.45M -63.51M -63.47M
    Net Income
    		 -70.47M -63.52M -63.47M
    Selling & General & Admin
    		 45.11M 35.47M 31.06M
    Research & Development
    		 59.72M 56.13M 57.3M
    Other Expenses
    		 n/a n/a n/a
    Operating Expenses
    		 104.83M 91.6M 88.36M
    Interest Expense
    		 n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a
    Cost & Expenses
    		 104.83M 91.6M 88.36M
    Income Tax Expense
    		 15K 8K 5K
    Shares Outstanding (Basic)
    		 60.94M 60.72M 60.58M
    Shares Outstanding (Diluted)
    		 60.94M 60.72M 60.58M
    EPS (Basic)
    		 -1.16 -1.05 -1.05
    EPS (Diluted)
    		 -1.16 -1.05 -1.05
    EBITDA
    		 -69.29M -62.48M -62.44M
    EBIT
    		 -70.63M -63.66M -63.6M
    Depreciation & Amortization
    		 1.16M 1.04M 1.03M

    Add to Watchlist